260 related articles for article (PubMed ID: 29185481)
1. Methamphetamine Induces Dopamine Release in the Nucleus Accumbens Through a Sigma Receptor-Mediated Pathway.
Hedges DM; Obray JD; Yorgason JT; Jang EY; Weerasekara VK; Uys JD; Bellinger FP; Steffensen SC
Neuropsychopharmacology; 2018 May; 43(6):1405-1414. PubMed ID: 29185481
[TBL] [Abstract][Full Text] [Related]
2. Methamphetamine induces Shati/Nat8L expression in the mouse nucleus accumbens via CREB- and dopamine D1 receptor-dependent mechanism.
Uno K; Miyazaki T; Sodeyama K; Miyamoto Y; Nitta A
PLoS One; 2017; 12(3):e0174196. PubMed ID: 28319198
[TBL] [Abstract][Full Text] [Related]
3. The role of reactive oxygen species in methamphetamine self-administration and dopamine release in the nucleus accumbens.
Jang EY; Yang CH; Hedges DM; Kim SP; Lee JY; Ekins TG; Garcia BT; Kim HY; Nelson AC; Kim NJ; Steffensen SC
Addict Biol; 2017 Sep; 22(5):1304-1315. PubMed ID: 27417190
[TBL] [Abstract][Full Text] [Related]
4. Methamphetamine increases dopamine release in the nucleus accumbens through calcium-dependent processes.
Yorgason JT; Hedges DM; Obray JD; Jang EY; Bills KB; Woodbury M; Williams B; Parsons MJ; Andres MA; Steffensen SC
Psychopharmacology (Berl); 2020 May; 237(5):1317-1330. PubMed ID: 31965252
[TBL] [Abstract][Full Text] [Related]
5. mRNA changes in nucleus accumbens related to methamphetamine addiction in mice.
Zhu L; Li J; Dong N; Guan F; Liu Y; Ma D; Goh EL; Chen T
Sci Rep; 2016 Nov; 6():36993. PubMed ID: 27869204
[TBL] [Abstract][Full Text] [Related]
6. Methamphetamine Activates Toll-Like Receptor 4 to Induce Central Immune Signaling within the Ventral Tegmental Area and Contributes to Extracellular Dopamine Increase in the Nucleus Accumbens Shell.
Wang X; Northcutt AL; Cochran TA; Zhang X; Fabisiak TJ; Haas ME; Amat J; Li H; Rice KC; Maier SF; Bachtell RK; Hutchinson MR; Watkins LR
ACS Chem Neurosci; 2019 Aug; 10(8):3622-3634. PubMed ID: 31282647
[TBL] [Abstract][Full Text] [Related]
7. Deletion of VGLUT2 in midbrain dopamine neurons attenuates dopamine and glutamate responses to methamphetamine in mice.
Shen H; Chen K; Marino RAM; McDevitt RA; Xi ZX
Pharmacol Biochem Behav; 2021 Mar; 202():173104. PubMed ID: 33444596
[TBL] [Abstract][Full Text] [Related]
8. Distinct dose-dependent effects of methamphetamine on real-time dopamine transmission in the rat nucleus accumbens and behaviors.
Bhimani RV; Vik M; Wakabayashi KT; Szalkowski C; Bass CE; Park J
J Neurochem; 2021 Aug; 158(4):865-879. PubMed ID: 34265079
[TBL] [Abstract][Full Text] [Related]
9. CM156, a high affinity sigma ligand, attenuates the stimulant and neurotoxic effects of methamphetamine in mice.
Kaushal N; Seminerio MJ; Shaikh J; Medina MA; Mesangeau C; Wilson LL; McCurdy CR; Matsumoto RR
Neuropharmacology; 2011; 61(5-6):992-1000. PubMed ID: 21762711
[TBL] [Abstract][Full Text] [Related]
10. The sigma-1 receptor as a regulator of dopamine neurotransmission: A potential therapeutic target for methamphetamine addiction.
Sambo DO; Lebowitz JJ; Khoshbouei H
Pharmacol Ther; 2018 Jun; 186():152-167. PubMed ID: 29360540
[TBL] [Abstract][Full Text] [Related]
11. Dopamine D
Tu G; Ying L; Ye L; Zhao J; Liu N; Li J; Liu Y; Zhu M; Wu Y; Xiao B; Guo H; Guo F; Wang H; Zhang L; Zhang L
Biol Psychiatry; 2019 Dec; 86(11):820-835. PubMed ID: 31060803
[TBL] [Abstract][Full Text] [Related]
12. Acupuncture inhibition of methamphetamine-induced behaviors, dopamine release and hyperthermia in the nucleus accumbens: mediation of group II mGluR.
Kim NJ; Ryu Y; Lee BH; Chang S; Fan Y; Gwak YS; Yang CH; Bills KB; Steffensen SC; Koo JS; Jang EY; Kim HY
Addict Biol; 2019 Mar; 24(2):206-217. PubMed ID: 29363229
[TBL] [Abstract][Full Text] [Related]
13. Sigma1 receptor antagonists determine the behavioral pattern of the methamphetamine-induced stereotypy in mice.
Kitanaka J; Kitanaka N; Tatsuta T; Hall FS; Uhl GR; Tanaka K; Nishiyama N; Morita Y; Takemura M
Psychopharmacology (Berl); 2009 May; 203(4):781-92. PubMed ID: 19052726
[TBL] [Abstract][Full Text] [Related]
14. Effects of subchronic methamphetamine exposure on basal dopamine and stress-induced dopamine release in the nucleus accumbens shell of rats.
Broom SL; Yamamoto BK
Psychopharmacology (Berl); 2005 Sep; 181(3):467-76. PubMed ID: 15986185
[TBL] [Abstract][Full Text] [Related]
15. Role of matrix metalloproteinase and tissue inhibitor of MMP in methamphetamine-induced behavioral sensitization and reward: implications for dopamine receptor down-regulation and dopamine release.
Mizoguchi H; Yamada K; Mouri A; Niwa M; Mizuno T; Noda Y; Nitta A; Itohara S; Banno Y; Nabeshima T
J Neurochem; 2007 Sep; 102(5):1548-1560. PubMed ID: 17472698
[TBL] [Abstract][Full Text] [Related]
16. Increased Vesicular Monoamine Transporter 2 (VMAT2; Slc18a2) Protects against Methamphetamine Toxicity.
Lohr KM; Stout KA; Dunn AR; Wang M; Salahpour A; Guillot TS; Miller GW
ACS Chem Neurosci; 2015 May; 6(5):790-9. PubMed ID: 25746685
[TBL] [Abstract][Full Text] [Related]
17. The role of tissue plasminogen activator in methamphetamine-related reward and sensitization.
Nagai T; Noda Y; Ishikawa K; Miyamoto Y; Yoshimura M; Ito M; Takayanagi M; Takuma K; Yamada K; Nabeshima T
J Neurochem; 2005 Feb; 92(3):660-7. PubMed ID: 15659235
[TBL] [Abstract][Full Text] [Related]
18. The role of organic cation transporter-3 in methamphetamine disposition and its behavioral response in rats.
Nakayama H; Kitaichi K; Ito Y; Hashimoto K; Takagi K; Yokoi T; Takagi K; Ozaki N; Yamamoto T; Hasegawa T
Brain Res; 2007 Dec; 1184():260-9. PubMed ID: 17988657
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA expression signature of methamphetamine use and addiction in the rat nucleus accumbens.
Sim MS; Soga T; Pandy V; Wu YS; Parhar IS; Mohamed Z
Metab Brain Dis; 2017 Dec; 32(6):1767-1783. PubMed ID: 28681200
[TBL] [Abstract][Full Text] [Related]
20. Neurochemical and behavioral differences between d-methamphetamine and d-amphetamine in rats.
Shoblock JR; Sullivan EB; Maisonneuve IM; Glick SD
Psychopharmacology (Berl); 2003 Feb; 165(4):359-69. PubMed ID: 12491026
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
